How are regulators tightening the “gray zone” of mental health advice by GenAI?
An FDA advisory discussion, updated guidance, and new state restrictions are converging to tighten oversight of generative AI tools used in mental health
An FDA advisory discussion, updated guidance, and new state restrictions are converging to tighten oversight of generative AI tools used in mental health
Lakeside Software’s returning CEO explains why decades of endpoint data have become the company’s biggest AI asset — and how the shift from visualization to reasoning is rewriting what IT teams can do